↓ Skip to main content

Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy

Overview of attention for article published in CNS Drugs, January 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
46 Mendeley
Title
Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
Published in
CNS Drugs, January 2020
DOI 10.1007/s40263-019-00687-3
Pubmed ID
Authors

Ryan D. Salinas, Joseph S. Durgin, Donald M. O’Rourke

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 46 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 20%
Student > Master 6 13%
Student > Bachelor 4 9%
Unspecified 3 7%
Student > Doctoral Student 3 7%
Other 4 9%
Unknown 17 37%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 17%
Agricultural and Biological Sciences 4 9%
Unspecified 3 7%
Medicine and Dentistry 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 7 15%
Unknown 19 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2021.
All research outputs
#15,470,154
of 24,527,858 outputs
Outputs from CNS Drugs
#1,093
of 1,367 outputs
Outputs of similar age
#256,068
of 466,863 outputs
Outputs of similar age from CNS Drugs
#15
of 22 outputs
Altmetric has tracked 24,527,858 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 466,863 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.